Cargando…
Hyaluronic acid in the treatment of dry eye disease
Dry eye disease (DED) is a highly prevalent and debilitating condition affecting several hundred million people worldwide. Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan commonly used in the treatment of DED. This review aims to critically evaluate the literature on the safety and e...
Autores principales: | Hynnekleiv, Leif, Magno, Morten, Vernhardsdottir, Ragnheidur R., Moschowits, Emily, Tønseth, Kim Alexander, Dartt, Darlene A., Vehof, Jelle, Utheim, Tor P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790727/ https://www.ncbi.nlm.nih.gov/pubmed/35514082 http://dx.doi.org/10.1111/aos.15159 |
Ejemplares similares
-
Review on the possible pathophysiological mechanisms underlying visual display terminal‐associated dry eye disease
por: Fjærvoll, Ketil, et al.
Publicado: (2022) -
Video display terminal use and dry eye: preventive measures and future perspectives
por: Kamøy, Bjørnar, et al.
Publicado: (2022) -
The relationship between habitual water intake and dry eye disease
por: Nguyen, Long, et al.
Publicado: (2022) -
The Relationship Between Caffeine Intake and Dry Eye Disease
por: Magno, Morten Schjerven, et al.
Publicado: (2023) -
Tear and Saliva Metabolomics in Evaporative Dry Eye Disease in Females
por: Fineide, Fredrik A., et al.
Publicado: (2023)